Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo

Metabolism: Clinical and Experimental

Volumn 63, Issue 1, 2014, Pages 150-160

  Chen, Wei ^a,b   Roncal Jimenez, Carlos ^a   Lanaspa, Miguel ^a   Gerard, Smits ^a   Chonchol, Michel ^a   Johnson, Richard J ^a,c   Jalal, Diana ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Mineral and bone disorders; Parathyroid hormone; Uric acid

Indexed keywords

1 ALPHA HYDROXYLASE; ALLANTOXANAMIDE; CREATININE; FEBUXOSTAT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OXYGENASE; PARATHYROID HORMONE; PHOSPHORUS; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HYPERURICEMIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; URIC ACID BLOOD LEVEL;

1,25 DIHYDROXY-VITAMIN D; 1,25(OH)(2)D; 25 HYDROXYVITAMIN D; 25(OH)D; ALLANTOXANAMIDE; ATX; BMI; BODY MASS INDEX; CHRONIC KIDNEY DISEASE; CKD; FBXT; FEBUXOSTAT; GFR; GLOMERULAR FILTRATION RATE; INTER-QUARTILE RANGE; IQR; MBD; MDRD; MINERAL AND BONE DISORDER; MINERAL AND BONE DISORDERS; MODIFICATION OF DIET IN RENAL DISEASE; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; NFΚB; NHANES; NUCLEAR FACTOR Κ- B; PARATHYROID HORMONE; PTH; URIC ACID;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERURICEMIA; IMMUNOBLOTTING; NF-KAPPA B P50 SUBUNIT; NUTRITION SURVEYS; ODDS RATIO; PARATHYROID HORMONE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES; URIC ACID; VITAMIN D;

EID: 84890121511     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.09.018     Document Type: Article

References (37)

1. A.S. Levey, R. Atkins, and J. Coresh Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes Kidney Int 72 3 2007 247 259
2. A.H. Brantsma, S.J. Bakker, and H.L. Hillege Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion Nephrol Dial Transplant 23 12 2008 3851 3858
3. A.S. Go, G.M. Chertow, and D. Fan Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
4. P.A. McCullough, C.T. Jurkovitz, and P.E. Pergola Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP) Arch Intern Med 167 11 2007 1122 1129
5. P.A. McCullough, S. Li, and C.T. Jurkovitz Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality Am Heart J 156 2 2008 277 283
6. D.E. Weiner, H. Tighiouart, and P.C. Stark Kidney disease as a risk factor for recurrent cardiovascular disease and mortality Am J Kidney Dis 44 2 2004 198 206
7. P. Muntner, J. He, and B.C. Astor Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities study J Am Soc Nephrol 16 2 2005 529 538
8. R. Agarwal Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD Clin J Am Soc Nephrol 4 9 2009 1523 1528
9. Z. Zhang, L. Sun, and Y. Wang Renoprotective role of the vitamin D receptor in diabetic nephropathy Kidney Int 73 2 2008 163 171
10. I.H. de Boer Vitamin D and glucose metabolism in chronic kidney disease Curr Opin Nephrol Hypertens 17 6 2008 566 572
11. D. Zehnder, M. Quinkler, and K.S. Eardley Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation Kidney Int 74 10 2008 1343 1353
12. X. Tan, X. Wen, and Y. Liu Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling J Am Soc Nephrol 19 9 2008 1741 1752
13. U. Lange, O. Jung, and J. Teichmann Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis Osteoporos Int 12 12 2001 1031 1035
14. R. Ebert, N. Schutze, and J. Adamski Vitamin D signaling is modulated on multiple levels in health and disease Mol Cell Endocrinol 248 1-2 2006 149 159
15. A. Levin, G.L. Bakris, and M. Molitch Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 1 2007 31 38
16. C.H. Hsu, S.R. Patel, and E.W. Young Effects of purine derivatives on calcitriol metabolism in rats Am J Physiol 260 4 Pt 2 1991 F596 F601
17. R. Vanholder, S. Patel, and C.H. Hsu Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure J Am Soc Nephrol 4 4 1993 1035 1038
18. S. Takahashi, T. Yamamoto, and Y. Moriwaki Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout Adv Exp Med Biol 431 1998 57 60
19. S. Takahashi, T. Yamamoto, and Y. Moriwaki Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout Metabolism 47 3 1998 336 338
20. C.M. Barrera, R.E. Hunter, and W.P. Dunlap Hyperuricemia and locomotor activity in developing rats Pharmacol Biochem Behav 33 2 1989 367 369
21. W.H. Church, and G. Rappolt Nigrostriatal catecholamine metabolism in guinea pigs is altered by purine enzyme inhibition Exp Brain Res 127 2 1999 147 150
22. Y. Takano, K. Hase-Aoki, and H. Horiuchi Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase Life Sci 76 16 2005 1835 1847
23. Y. Osada, M. Tsuchimoto, and H. Fukushima Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents Eur J Pharmacol 241 2-3 1993 183 188
24. V. Douard, A. Asgerally, and Y. Sabbagh Dietary fructose inhibits intestinal calcium absorption and induces vitamin D insufficiency in CKD J Am Soc Nephrol 21 2 2010 261 271
25. R. Ebert, M. Jovanovic, and M. Ulmer Down-regulation by nuclear factor kappaB of human 25-hydroxyvitamin D3 1alpha-hydroxylase promoter Mol Endocrinol 18 10 2004 2440 2450
26. J. Kanellis, S. Watanabe, and J.H. Li Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 Hypertension 41 6 2003 1287 1293
27. H.J. Han, M.J. Lim, and Y.J. Lee Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB Am J Physiol Renal Physiol 292 1 2007 F373 F381
28. The National Health and Nutrition Examination Survey reference manuals and reports (2003-2006), National Center for Health Statistics: Bethesda.
29. G.A. Block, P.S. Klassen, and J.M. Lazarus Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 8 2004 2208 2218
30. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
31. F. Saleh, R. Jorde, and J. Sundsfjord Causes of secondary hyperparathyroidism in a healthy population: the Tromso study J Bone Miner Metab 24 1 2006 58 64
32. Ybarra J, Donate T, Jurado J, et al. Primary hyperparathyroidism, insulin resistance, and cardiovascular disease: a review. Nurs Clin North Am, 2007. 42(1): p. 79-85, vii.
33. P. Vestergaard, C.L. Mollerup, and V.G. Frokjaer Cardiovascular events before and after surgery for primary hyperparathyroidism World J Surg 27 2 2003 216 222
34. I. Kippen, N. Nakata, and J.R. Klinenberg Uptake of uric acid by separated renal tubules of the rabbit. I. Characteristics of transport J Pharmacol Exp Ther 201 1 1977 218 225
35. K. Kohri, M. Takada, and Y. Katoh Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide Br J Urol 59 6 1987 503 507
36. D. Zehnder, R. Bland, and R.S. Chana Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion J Am Soc Nephrol 13 3 2002 621 629
37. K. Stoffels, L. Overbergh, and A. Giulietti Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes J Bone Miner Res 21 1 2006 37 47